Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of CBT-I and Lemborexant Medication for Different Subtypes of Chronic Insomnia

NCT06779149 is registered in ClinicalTrials.gov with Laval University as lead sponsor.

NCT NCT06779149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06779149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of CBT-I and Lemborexant Medication for Different Subtypes of Chronic Insomnia
Lead sponsor
Laval University
Phase
Not applicable
Overall status
Recruiting
Start date
April 1, 2025
Completion date
February 28, 2027
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia disorder